ArticleOphthalmology science

HORNBILL: A First-in-Human Phase I/IIa Study of the Safety, Tolerability, and Early Pharmacodynamics of BI 764524 for Diabetic Macular Ischemia.

Quan Dong Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.